European Archives - Page 1134 of 1554 - European Medical Journal

Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other

Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…

Editor's Pick: Acne Therapy Across Time in the USA

Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…

Review of the 2019 European Academy of Dermatology and Venereology 28th Congress

Madrid, a city characterised by elegance and culture, welcomed an influx of dermatologists this Autumn for the annual European Academy of Dermatology…

Anxiety and Depression in Family Members and Caregivers of Preschool Children with Atopic Dermatitis

Anxiety and depression are often overlooked and underdiagnosed in both patients with atopic dermatitis (AD) and their family members and preschool…

EMJ Dermatology 7.1

This year’s European Academy of Dermatology and Venereology (EADV) Congress, hosted by the vibrant city of Madrid, Spain…

Alternative Medicine use in Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic, incurable disease of apocrine gland-bearing skin, which presents with painful nodules and scarring most…

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review

Atopic dermatitis (AD) is one of the most common and debilitating chronic inflammatory skin diseases, often greatly affecting physical, economical…

Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis

The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…

Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases

Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…

Dermatomyositis Revealing Bladder Cancer Recurrence

There is a well-recognised association between inflammatory dermatomyopathy, dermatomyositis, and underlying visceral malignancy in adults.